Related Experiment Videos
Can we produce a human corneal equivalent by tissue engineering?
L Germain1, P Carrier, F A Auger
1Laboratoire d'Organogénèse Expérimentale (LOEX), CHA Pavillon Saint-Sacrement, Qc, G1 S 4L8, Québec, Canada. lucie.germain@chg.ulaval.ca
Progress in Retinal and Eye Research
|August 5, 2000
Summary
Tissue engineering advances have led to bioengineered human cornea models. These models aid in understanding corneal wound healing and offer future experimental and clinical applications.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Tissue Engineering
Background:
- Tissue engineering is rapidly advancing, with bioengineered substitutes available for various applications.
- Reconstructed human cornea models are being developed for research and clinical use.
Purpose of the Study:
- To review the development of in vitro reconstructed human cornea using tissue engineering.
- To discuss key elements, production steps, and wound healing mechanisms in corneal reconstruction.
- To analyze the role of integrins and extracellular matrix components in corneal wound healing.
Main Methods:
- Review of tissue engineering strategies for corneal reconstruction.
- Analysis of epithelial and keratocyte cell sources.
- Immunohistofluorescence labeling to detect integrin subunits and extracellular matrix components in reconstructed cornea.
Main Results:
- Identified key elements and production steps for in vitro human cornea reconstruction.
- Revealed expression of beta(1), alpha(3), alpha(5), and alpha(6) integrin subunits, with absence of alpha(4).
- Detected laminin, type VII collagen, and fibronectin in the reconstructed cornea.
Conclusions:
- In vitro reconstructed human cornea models are valuable for studying corneal wound healing.
- These models demonstrate the expression of specific integrins and extracellular matrix components.
- Future challenges and significant experimental/clinical applications of engineered cornea are highlighted.